82 related articles for article (PubMed ID: 21500354)
1. A tetrazolato-bridged dinuclear platinum(II) complex exhibits markedly high in vivo antitumor activity against pancreatic cancer.
Komeda S; Lin YL; Chikuma M
ChemMedChem; 2011 Jun; 6(6):987-90. PubMed ID: 21500354
[No Abstract] [Full Text] [Related]
2. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
[TBL] [Abstract][Full Text] [Related]
4. Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.
Jun YJ; Kim JI; Jun MJ; Sohn YS
J Inorg Biochem; 2005 Aug; 99(8):1593-601. PubMed ID: 15963570
[TBL] [Abstract][Full Text] [Related]
5. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
[TBL] [Abstract][Full Text] [Related]
6. Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity.
Xue Z; Lin M; Zhu J; Zhang J; Li Y; Guo Z
Chem Commun (Camb); 2010 Feb; 46(8):1212-4. PubMed ID: 20449253
[TBL] [Abstract][Full Text] [Related]
7. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands.
Woodhouse SL; Ziolkowski EJ; Rendina LM
Dalton Trans; 2005 Sep; (17):2827-9. PubMed ID: 16094469
[TBL] [Abstract][Full Text] [Related]
9. Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
Komeda S; Yoneyama H; Uemura M; Muramatsu A; Okamoto N; Konishi H; Takahashi H; Takagi A; Fukuda W; Imanaka T; Kanbe T; Harusawa S; Yoshikawa Y; Yoshikawa K
Inorg Chem; 2017 Jan; 56(2):802-811. PubMed ID: 28045514
[TBL] [Abstract][Full Text] [Related]
10. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
11. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
12. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.
Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
J Inorg Biochem; 2019 Mar; 192():82-86. PubMed ID: 30612029
[TBL] [Abstract][Full Text] [Related]
14. Platinum(IV) anticancer complexes.
Hall MD; Dolman RC; Hambley TW
Met Ions Biol Syst; 2004; 42():297-322. PubMed ID: 15206106
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
Zhang J; Li Y; Sun J; Li W; Gong Y; Zheng X; Cui J; Wang R; Wu J
Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
[TBL] [Abstract][Full Text] [Related]
17. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of six dinuclear platinum(II) complexes.
Yu C; Gao C; Bai L; Liu Q; Zhang Z; Zhang Y; Yang B; Li C; Dong P; Sun X; Qian Y
Bioorg Med Chem Lett; 2017 Feb; 27(4):963-966. PubMed ID: 28109784
[TBL] [Abstract][Full Text] [Related]
20. [Anti-tumor efficacy of interventional chemotherapy with liposomal doxorubicin for hepatic metastasis of pancreatic cancer in nude mouse model].
Xie YB; Wang Z; Han ZK; Li AD; Zhang ZQ; Li H; Ma J; Zhao P
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2126-9. PubMed ID: 21029629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
